Answer
No. It is a non-prostanoid treatment that selectively activates the IP receptor involved in prostacyclin signalling.
Sources for this answer
- Uptravi 1400 microgram film-coated tablets (Great Britain)emc · SmPC Current selected SmPC · Version 7